Bacterial vaccines for fish - An update of the current situation worldwide

Developments in Biologicals

Volumn 121, Issue , 2005, Pages 55-74

  Hastein T ^a   Gudding, R ^a   Evensen, O ^b  

^a NORWEGIAN VETERINARY INSTITUTE   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE;

ANIMAL; ANIMAL DISEASE; AQUACULTURE; BACTERIAL INFECTION; COMPARATIVE STUDY; FISH; FISH DISEASE; METHODOLOGY; MICROBIOLOGY; QUESTIONNAIRE; REVIEW;

ANIMALS; AQUACULTURE; BACTERIAL INFECTIONS; BACTERIAL VACCINES; FISH DISEASES; FISHES; QUESTIONNAIRES;

EID: 14744271771     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (49)

1. Press C, Lillehaug A: Vaccination in European salmonid aquaculture: A review of practises and prospects. Br Vet J 1995; 151: 46-69.
2. Gudding R, Lillehaug A; Evensen Ø: Recent developments in fish vaccinology. Vet Immunol Immunpathol 1999; 72: 203-212.
3. Bowden T, Bricknell I, Ellis T: Fish vaccination, an overview. Intrafish, Industry Report, 2003, p 20.
4. Ellis A: Vaccines for farmed fish, in Pastoret PP, Blancou J, Vannier P, Verschueren C, (eds): Veterinary Vaccinology. Amsterdam, Elsevier, 1997, pp 411-417.
5. rd International Symposium on Fish Vaccinology, 2003, p 59.
6. Myhr E, Larsen JL, Lillehaug A, Gudding R, Heum M, Håstein T: Characterization of Vibrio anguillarum and closely related species isolated from farmed fish in Norway. Appl & Environ Microbiol 1991; 57: 2750-2757.
7. Boesen HT, Pedersen C, Larsen JL, Koch K, Ellis T: Vibrio anguillarum resistance to rainbow trout (Oncorhynchus mykiss) serum: role of O-antigen structure of lipopolysaccharide. Inf Immun 1999; 67: 294-301.
8. Actis LA, Potter SA, Crosa JH: Iron-regulated outer membrane protein OM2 of Vibrio anguillarum is encoded by virulence plasmid pJM1. J Bacteriol 1985; 161 (2): 736-742.
9. rd International Symposium on Fish Vaccinology, 2003, p 44.
10. Bull Eur Ass FishPathol 1994b; 14: 120-122.
11. Schrøder MB, Espelid S, Jørgensen TØ: Two sero-type of Vibrio salmonicida isolated from diseased cod (Gadus morhua L.); virulence, immunological studies and vaccination experiments. Fish Shellfish Immunology 1991; 2: 211-221.
12. Colquhoun D, Alvheim K, Dommarsnes K, Syvertsen C, Sørum H: Relevance of incubation temperature for Vibrio salmonicida vaccine production. J Appl Microbiol 2002; 92: 1087-1096.
13. Garduno RA, Kay WW: Capsulated cells of Aeromonas salmonicida grown in vitro have different functional properties than capsulated cells grown in vivo. Can J Microbiol 1995; 41 (10): 941-945.
14. Fernandez AI, Fernandez AF, Perez MJ, Nieto TP, Ellis AE: Siderophore production by Aeromonas salmonicida subsp. salmonicida. Lack of strain specificity. Dis Aquat Org 1998; 33 (2): 87-92
15. Midtlyng P, Reitan LJ, Speilberg L: Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L) against furunculosis. Fish Shellfish Immunol 1996; 6: 335-350.
16. Lund V, Arnesen JA, Coucheron D, Modalsli K, Syvertsen C: The Aeromonas salmonicida A-layer protein is an important protective antigen in oil-adjuvanted vaccines. Fish Shellfish Immunol 2003; 15: 367-372.
17. Hoel K, Reitan LJ, Lillehaug A: Immunological crossreactions between Aeromonas salmonicida and Vibrio salmonicida in Atlantic salmon (Salmo salar L.) and rabbit. Fish Shellfish Immunology 1998; 8: 171-182.
18. Gudmundsdóttir S, Lange S, Magnadóttir B, Gudmundsdóttir BK: Protection against atypical furunculosis in Atlantic halibut, Hippoglossus hippoglossus (L.); comparison of a commercial furunculosis vaccine and an autogenous vaccine. J Fish Dis 2003; 26 (6): 331-338.
19. Lunder T, Evensen Ø, Holstad G, Håstein T: «Winter ulcer» in the Atlantic salmon Salmo salar. Pathological and bacteriological investigations and transmission experiments. Dis Aquatic Org 1995; 23:39-49.
20. Vinitnantharat S, Gravningen K, Greger E: Fish vaccines. Adv Vet Med 1999; 41: 539-550.
21. Gravningen K, Thorarinsson R, Johansen LH, Nissen B, Rikardsen KS, Greger E, Vigneulle M: Bivalent vaccines for sea bass (Dicentrachus labrax) against vibriosis and pasteurellosis. J Appl Ichthyol 1998; 14: 159-162.
22. Romalde JL: Photobacterium damselae subsp. piscicida: an integrated view of a bacterial fish pathogen. Int Microbiol 2002; 5:3-9.
23. Magarinõs B, Romalde JL, Noya M, Barja, JL, Toranzo, AE: Adherence and invasive capacities of the fish pathogen Pasteurella piscicida. FEMS Microbiol Lett 1996; 138: 29-34.
24. Magarinõs B, Romalde JL, Lemos, ML, Barja JL, Toranzo AE: Iron uptake by Pasteurella piscicida and its role in pathogenicity for fish. Appl Environ Microbiol 1994a; 60: 2990-2998.
25. Magarinõs B, Santos Y, Romalde JL, Rivas C, Barja JL, Toranzo AE: Pathogenic activities of live cells and extracellular products of the fish pathogen Pasteurella piscicida. J Gen Microbiol 1992; 138: 2491-2498.
26. Magarinõs B, Noya M, Romalde JL, Perez G, Toranzo AE: Influence of fish size and vaccine formulation on the protection of gilthead seabream against Pasteurella piscicida.
27. Amaro C, Fouz B, Collado R, Esteve-Gassent D, Marco-Noales E, Esteve C, Barrera R, Alcaide E: Diseno y desarrollo de una vacuna contra la vibriosis producida por Vibrio vulnificus Serovar E (o biotipo 2) en anguilas, con aplicacion en piscifactorias dedicadas al cultivo intensivo. (Design and development of a vaccine against eel vibriosis caused by Vibrio vulnificus serovar E (or biotype 2) applied to intensive culture facilities. Ministerio de Agricultura, Pesca y Alimentacion, Secretaria General Technica N.I.P.O. 251-02-007-3, 2001, 29 pp.
28. Collado R, Fouz B, Sanjuan E, Amaro C: Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eel (Anguilla anguilla). Dis Aquatic Org 2000; 43: 891-101.
29. Fouz B, Esteve-Gassent MD, Barrera R, Larsen JL, Nielsen ME, Amaro C: Field testing of a vaccine against eel diseases caused by Vibrio vulnificus. Dis Aqua Org 2001; 45: 183-189.
30. Balebona MC, Zorilla I, Moriñigo MA, Borrego JJ: Survey of bacterial pathologies affecting farmed gilt-head sea bream (Sparus aurata L.) in south-western Spain from 1990 to 1996. Aquaculture 1998; 166: 19-35.
31. Romalde JL, Magariños B: Immunization with bacterial antigenes: Pasteurellosis, in Gudding R, Lillehaug A, Midtlyng PJ, Brown F (eds): Fish Vaccinology. Basel, Karger, 1997, vol 90, pp167-177.
32. Moriñigo MA, Romalde JL, Chabrillon M, Magariños B, Arijo S, Balebona MC, Toranzo AE: Effectiveness of a divalent vaccine for gilt-head sea bream (Sparus aurata) against Vibrio alginolyticus and Photobacterium damsela subspecies piscicida. Bull Eur Ass Fish Pathol 2002; 22 (5): 298-303.
33. Thune RL, Hawke JP, Fernandez DH, Laurence ML, Moore MM: Immunization with bacterial antigens: Edwardsiellosis, in Gudding R, Lillehaug A, Midtlyng PJ, Brown F (eds): Fish Vaccinology. Basel, Karger, 1997, vol 90, pp 167-177.
34. Klesius PH, Shoemaker CA: Development and use of modified live Edwardsiella ictaluri vaccine against enteric septicemia of catfish. Adv Vet Med 1999; 41: 523-537.
35. rd International Symposium on Fish Vaccinology, 2003, p 52.
36. LaFrentz BR, LaPatra SE, Jones GR, Cain KD: Passive immunization of rainbow trout, Oncorhynchus mykiss (Walbaum), against Flavobacterium psychrophilum, the causative agent of bacterial coldwater disease and rainbow trout fry syndrome. J Fish Dis 2003; 26: 377-384.
37. rd International Symposium on Fish Vaccinology, 2003, p 91.
38. Austin B, Austin DA: Bacterial Fish Pathogenes: Diseases of farmed and wild fish. Third edition, Springer Verlag in association with Praxis Publishing, Chichester. ISBN 1-85233-12-8. 1999, pp 457.
39. Roberts RJ: Streptococcus iniae, in Roberts RJ (ed): Fish Pathology, W.B. Saunders, 2001, p 324.
40. Bromage ES, Owens L: Infection of barramundi Lates calcarifer with Streptococcus iniae: effects of different routes of exposure. Dis Aquat Org 2002; 52 (3): 199-205.
41. Barnes AC, Guyot C, Hanse BG, Mackenzie K, Horn MT, Ellis AE: Resistance to serum killing may contribute to differences in the abilities of capsulate and non-capsulated isolates of Lactococcus garvieae to cause disease in rainbow trout (Oncorhynchus mykiss L.). Fish Shellfish Immunol 2002; 12 (2): 155-168.
42. Ooyama T, Hirokawa Y, Minami T, Yasuda H, Nakai T, Endo M, Ruangpan L, Yoshida T. Cell-surface properties of Lactococcus garvieae strains and their immunogenicity in the yellowtail Seriola quinqueradiata. Dis Aquat Org 2002; 51 (3): 169-177.
43. Toranzo AE, Devesa S, Romalde JL, Lamas J, Riaza A, Leiro J, Barja JL: Efficacy of intraperitoneal and immersion vaccination against Enterococcus sp. infection in turbot. Aquaculture 1995; 134: 17-27.
44. Fryer JL, Hedrick RP: Piscirickettsia salmonis: a Gram-negative intracellular bacterial pathogen of fish. J Fish Dis 2003; 26 (5): 251-262.
45. Mauel MJ, Giovannoni SJ, Fryer JL: Phylogenetic analysis of Piscirickettsia salmonis by 16S, internal transcribed spacer (ITS) and 23S ribosomal DNA sequencing. Dis Aquat Org 1999; 35 (2): 115-123.
46. Kuzyk MA, Burian J, Machander D, Dolhaine D, Cameron S, Thornton JC, Kay WW: An efficacious recombinant subunit vaccine against the salmonid rickettsial pathogen Piscirickettsia salmonis Vaccine 2001; 19 (17-19): 2337-2344.
47. rd International Symposium on Fish Vaccinology, 2003, p 60.
48. rd International Symposium on Fish Vaccinology, 2003, p 41.
49. Bandin I, Santos Y, Margariños B, Barja JL, Toranzo AE: The detection of two antigenic groups among Renibacterium salmoninarum isolates. FEMS Microbiol Letters 1992; 94: 105-110.